title: [Choriocarcinoma].
authors.affiliation: Jena.
authors.forename: A
authors.initials: A
authors.lastname: Petrovitch
authors.forename: H
authors.initials: H
authors.lastname: Diebolder
authors.forename: C
authors.initials: C
authors.lastname: Kurrat
authors.forename: I B
authors.initials: IB
authors.lastname: Runnebaum
authors.forename: W
authors.initials: W
authors.lastname: Kaiser
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002822:Choriocarcinoma / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy / Q000556:secondary; D018997:Chorionic Gonadotropin, beta Subunit, Human / Q000097:blood; D002945:Cisplatin / Q000008:administration & dosage; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008175:Lung Neoplasms / Q000000981:diagnostic imaging / Q000188:drug therapy / Q000556:secondary; D008279:Magnetic Resonance Imaging; D049590:Postpartum Period; D011247:Pregnancy; D013902:Radiography, Thoracic; D012307:Risk Factors; D013997:Time Factors; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome; D014594:Uterine Neoplasms / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy
chemical_list: D018997:Chorionic Gonadotropin, beta Subunit, Human; D005047:Etoposide; D002945:Cisplatin